Autologous Serum and Recombinant Nerve Growth Factor in the Complex Treatment of Neurotrophic Keratitis
https://doi.org/10.18008/1816-5095-2024-4-777-785
Abstract
Neurotrophic keratitis is a frequent complication of neurosurgical interventions caused by a loss of corneal sensitivity due to damage of the trigeminal nerve pathway. The article presents a clinical case of a successful treatment of a neurotrophic corneal ulcer developed after removal of a giant trigeminal neurinoma. Treatment with autologous serum instillations made it possible to achieve ulcer healing and unstable corneal epithelialization. Stable epithelialization was achieved after temporary replacement of the autologous serum topical application with recombinant human nerve growth factor. In addition to ulcer healing and complete corneal epithelialization, regeneration of nerve fibers was noted (according to cornea confocal microscopy data).
About the Authors
E. A. KasparovaRussian Federation
Kasparova Evgeniya А., PhD, leading researcher of Pathology of Optical Media
of the Eye Department
Rossolimo str., 11A, B, Moscow, 119021
Z. V. Surnina
Russian Federation
Surnina Zoya V., MD, senior researcher at the Department of Pathology
of Optical Media of the Eye
Rossolimo str., 11A, B, Moscow, 119021
N. R. Marchenko
Russian Federation
Marchenko Nikolay R., PhD, researcher at the Department of Pathology
of Optical Media of the Eye
Rossolimo str., 11A, B, Moscow, 119021
L. S. Pateyuk
Russian Federation
Pateyuk Lyudmila S., PhD, senior researcher at the Department of Pathology
of Optical Media of the Eye
Rossolimo str., 11A, B, Moscow, 119021
V. D. Yartsev
Russian Federation
Yartsev Vasily D., PhD, leading researcher at the Department of Pathology
of the lacrimal tract
Rossolimo str., 11A, B, Moscow, 119021
References
1. Sigelman S, Friedenwald JS. Mitotic and wound healing activities of the corneal epithelium: effect of sensory denervation. Arch Ophthalmol. 1954;52:46–57.
2. Mackie IA. Neuroparalytic keratitis. In: Fraunfelder F, Roy FH, Meyer SM, editors. Current Ocular Therapy. Philadelphia, PA, USA: WB Saunders; 1995:452–454.
3. Dua HS, Said DG, Messmer EM, Rolando M, BenitezDelCastillo JM, Hossain PN, Shortt AJ, Geerling G, Nubile M, Figueiredo FC, Rauz S, Mastropasqua L, Rama P, Baudouin C. Neurotrophic keratopathy. Prog Retin Eye Res. 2018;66:107–131. doi: 10.1016/j.preteyeres.2018.04.003.
4. Kasparova E.A., Marchenko N.R. Neurotrophic Keratitis. Etiology, Pathogenesis, Clinical Manifestations. Review. Part 2. Ophthalmology. 2022;19(2):265–271 (In Russ.). doi: 10.18008/1816-5095-2022-2-265-27.
5. Brzheskiy VV, Popov VYu, Efimova EL, Golubev SYu. Modern capabilities in diagnosis and treatment of neurotrophic keratopathy. Annals of Ophthalmology. 2022;138(6):123–132 (In Russ.). doi: 10.17116/oftalma2022138061123.
6. Muller L.J., Marfurt C.F., Kruse F., Tervo T.M. Corneal nerves: structure, contents and function. Exp Eye Res. 2003;76(5):521–542. doi: 10.1016/s0014-4835(03)000502.
7. Oddone F, Roberti G, Micera A, Busanello A, Bonini S, Quaranta L, Agnifili L, Manni G. Exploring serum levels of brain derived neurotrophic factor and nerve growth factor across glaucoma stages. PLoS One. 2017;12(1):e0168565. doi: 10.1371/journal.pone.0168565.
8. Park KS, Kim SS, Kim JC, Kim HC, Im YS, Ahn CW, Lee HK. Serum and tear levels of nerve growth factor in diabetic retinopathy patients. Am J Ophthalmol. 2008;145(3):432–437. doi: 10.1016/j.ajo.2007.11.011.
9. Mastropasqua L., Lanzini M., Dua H.S., D’ Uffizi A., Di Nicola M., Calienno R., Bond. J., Said D.G., Nubile M. In Vivo Evaluation of Corneal Nerves and Epithelial Healing After Treatment With Recombinant Nerve Growth Factorfor Neurotrophic Keratopathy. Am J Ophthalmol. 2020;217:278–286. doi: 10.1016/j.ajo.2020.04.036.
Review
For citations:
Kasparova E.A., Surnina Z.V., Marchenko N.R., Pateyuk L.S., Yartsev V.D. Autologous Serum and Recombinant Nerve Growth Factor in the Complex Treatment of Neurotrophic Keratitis. Ophthalmology in Russia. 2024;21(4):777-785. (In Russ.) https://doi.org/10.18008/1816-5095-2024-4-777-785